Q3 2021 Kiniksa Pharmaceuticals Ltd Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Kiniksa Pharmaceuticals Third Quarter Conference Call. (Operator Instructions)
I would now like to hand the conference over to your speaker today, Ms. Rachel Frank. Ms. Frank, you may begin.
Thank you, operator. Good morning, everyone, and thank you for joining Kiniksa's call to discuss our third quarter 2021 financial results and our recent corporate and pipeline activity. A press release highlighting these results can be found on our website under the Investors & Media section.
As for the agenda, our Chief Executive Officer, Sanj K. Patel, will start with an introduction. Ross Moat, our Head of Commercial, will provide an update on the ARCALYST commercial launch; Eben Tessari, Kiniksa's Chief Business Officer, will follow with a brief pipeline review. Mark Ragosa, our Chief Financial Officer, will review our third quarter 2021 financial results. And finally, Sanj will return for closing remarks and to kick off
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |